These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 29255910

  • 21. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.
    Pathak A, Rudolph UM, Saxena M, Zeller T, Müller-Ehmsen J, Lipsic E, Schmieder RE, Sievert H, Halbach M, Sharif F, Parise H, Fischell TA, Weber MA, Kandzari DE, Mahfoud F.
    EuroIntervention; 2023 Sep 18; 19(7):602-611. PubMed ID: 37427416
    [Abstract] [Full Text] [Related]

  • 22. Renal sympathetic denervation: early impact on ambulatory resistant hypertension.
    Schwerg M, Heupel C, Strajnic D, Baumann G, Laule M, Stangl V, Stangl K.
    J Clin Hypertens (Greenwich); 2014 Jun 18; 16(6):406-11. PubMed ID: 24766570
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation.
    Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, Wang Y, Saxena M, Lurz P, Sayer J, Bloch MJ, Basile J, Weber MA, Rump LC, Levy T, Sapoval M, Sanghvi K, Rader F, Fisher NDL, Gosse P, Abraham J, Claude L, Barman NC, McClure CK, Liu Y, Kirtane AJ, RADIANCE-HTN Investigators.
    JACC Cardiovasc Interv; 2020 Dec 28; 13(24):2922-2933. PubMed ID: 33357531
    [Abstract] [Full Text] [Related]

  • 25. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015 Dec 28; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 26. First-in-Man Experience with a Novel Catheter-Based Renal Denervation System of Ultrasonic Ablation in Patients with Resistant Hypertension.
    Chernin G, Szwarcfiter I, Scheinert D, Blessing E, Diehm N, Dens J, Walton A, Verheye S, Shetty S, Jonas M.
    J Vasc Interv Radiol; 2018 Aug 28; 29(8):1158-1166. PubMed ID: 29921526
    [Abstract] [Full Text] [Related]

  • 27. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
    Tsioufis C, Ziakas A, Dimitriadis K, Davlouros P, Marketou M, Kasiakogias A, Thomopoulos C, Petroglou D, Tsiachris D, Doumas M, Skalidis E, Karvounis C, Alexopoulos D, Vardas P, Kallikazaros I, Stefanadis C, Papademetriou V, Tousoulis D.
    Clin Res Cardiol; 2017 May 28; 106(5):322-330. PubMed ID: 27957627
    [Abstract] [Full Text] [Related]

  • 28. Renal denervation in patients with resistant hypertension: six-month results.
    Dores H, de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Gaspar A, Sousa H, Canha Gomes A, Andrade MJ, Carvalho MS, Campante Teles R, Raposo L, Mesquita Gabriel H, Pereira Machado F, Mendes M.
    Rev Port Cardiol; 2014 Apr 28; 33(4):197-204. PubMed ID: 24472425
    [Abstract] [Full Text] [Related]

  • 29. Randomized Trials of Renal Denervation for Uncontrolled Hypertension: An Updated Meta-Analysis.
    Mufarrih SH, Qureshi NQ, Khan MS, Kazimuddin M, Secemsky E, Bloch MJ, Giri J, Cohen D, Swaminathan RV, Feldman DN, Alaswad K, Kirtane A, Kandzari D, Aronow HD.
    J Am Heart Assoc; 2024 Aug 20; 13(16):e034910. PubMed ID: 39140334
    [Abstract] [Full Text] [Related]

  • 30. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb 20; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 31. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A.
    Hypertension; 2013 Sep 20; 62(3):526-32. PubMed ID: 23836798
    [Abstract] [Full Text] [Related]

  • 32. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial.
    de Jager RL, de Beus E, Beeftink MM, Sanders MF, Vonken EJ, Voskuil M, van Maarseveen EM, Bots ML, Blankestijn PJ, SYMPATHY Investigators.
    Hypertension; 2017 Apr 20; 69(4):678-684. PubMed ID: 28264922
    [Abstract] [Full Text] [Related]

  • 33. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K, Rommel KP, Lapusca R, Blazek S, Besler C, Hartung P, von Roeder M, Kresoja KP, Desch S, Thiele H, Lurz P.
    Hypertension; 2019 Aug 20; 74(2):341-348. PubMed ID: 31203726
    [Abstract] [Full Text] [Related]

  • 34. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner.
    Schirmer SH, Sayed MM, Reil JC, Lavall D, Ukena C, Linz D, Mahfoud F, Böhm M.
    JACC Cardiovasc Interv; 2015 Jun 20; 8(7):972-80. PubMed ID: 26003031
    [Abstract] [Full Text] [Related]

  • 35. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    Wang L, Li C, Li Z, Li Q, Liu C, Sun X, He Q, Xia DS, Xia D, Lu C.
    J Hypertens; 2024 May 01; 42(5):801-808. PubMed ID: 38164953
    [Abstract] [Full Text] [Related]

  • 36. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S.
    Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375
    [Abstract] [Full Text] [Related]

  • 37. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M.
    Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238
    [Abstract] [Full Text] [Related]

  • 38. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A, Calvo C, García-Puig J, Gil-Extremera B, Aguilera MT, de la Sierra A, Martín-Hidalgo A, Marín R, MAPAVEL Investigators (Monitorizacíon Ambulatoria Presión Arterial APROVEL).
    Clin Ther; 2002 Jan 30; 24(1):126-38. PubMed ID: 11833827
    [Abstract] [Full Text] [Related]

  • 39. Results of a randomized controlled pilot trial of intravascular renal denervation for management of treatment-resistant hypertension.
    Jacobs L, Persu A, Huang QF, Lengelé JP, Thijs L, Hammer F, Yang WY, Zhang ZY, Renkin J, Sinnaeve P, Wei FF, Pasquet A, Fadl Elmula FEM, Carlier M, Elvan A, Wunder C, Kjeldsen SE, Toennes SW, Janssens S, Verhamme P, Staessen JA, European Network Coordinating Research on Renal Denervation.
    Blood Press; 2017 Dec 30; 26(6):321-331. PubMed ID: 28489464
    [Abstract] [Full Text] [Related]

  • 40. Vascular and renal hemodynamic changes after renal denervation.
    Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.
    Clin J Am Soc Nephrol; 2013 Jul 30; 8(7):1195-201. PubMed ID: 23559677
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.